{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T20:53:15Z","timestamp":1788209595809,"version":"build-2803163510"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T00:00:00Z","timestamp":1683504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Outcomes after acute coronary syndromes (ACS) are determined by baseline risk profiles, including initial systolic blood pressure (sBP) levels. Herein, we aimed to characterize ACS patients stratified by initial sBP levels and study their relation to inflammation, myocardial injury and post-ACS outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>We analysed 4724 prospectively recruited ACS patients according to invasively assessed sBP (&amp;lt;100, 100\u2013139, and \u2265140 mmHg) at admission. Biomarkers of systemic inflammation [high-sensitivity C-reactive protein (hs-CRP)] and myocardial injury [high-sensitivity cardiac troponin T (hs-cTnT)] were measured centrally. Major adverse cardiovascular events (MACE; composite measure of non-fatal myocardial infarction, non-fatal stroke, and cardiovascular death) were externally adjudicated. Leukocyte counts, hs-CRP, hs-cTnT, and creatine kinase (CK) levels decreased from low to high sBP strata (ptrend &amp;lt; 0.001). Patients with sBP &amp;lt; 100 mmHg developed more often cardiogenic shock (CS; P &amp;lt; 0.001), and had a 1.7-fold increased multivariable-adjusted MACE risk at 30 days (HR 1.68, 95% CI 1.05\u20132.69, P = 0.031) which did not persist at one year (HR 1.38, 95% CI 0.92\u20132.05, P = 0.117). Those with sBP &amp;lt; 100 mmHg and CS showed a higher leukocyte count (P &amp;lt; 0.001), an increased neutrophil-to-lymphocyte-ratio (P = 0.031), and higher hs-cTnT and CK levels relative to those without CS (P &amp;lt; 0.001 and P = 0.002, respectively), whereas hs-CRP levels did not differ. Patients who developed CS had a 3.6- and 2.9-fold increased MACE risk at 30 days (HR 3.58, 95% CI 1.77\u20137.24, P &amp;lt; 0.001) and at one year (HR 2.94 95% CI, 1.57\u20135.53, P &amp;lt; 0.001), which was intriguingely attenuated after controlling for distinct inflammatory profiles.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>In patients with ACS, proxies of systemic inflammation and myocardial injury are inversely associated with initial sBP levels, with highest biomarker levels observed in those &amp;lt;100 mmHg. If linked to high levels of cellular inflammation, these patients are prone to develop CS and are at high MACE and mortality risk.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjacc\/zuad047","type":"journal-article","created":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T18:32:38Z","timestamp":1683570758000},"page":"437-450","source":"Crossref","is-referenced-by-count":10,"title":["Initial systolic blood pressure associates with systemic inflammation, myocardial injury, and outcomes in patients with acute coronary syndromes"],"prefix":"10.1093","volume":"12","author":[{"given":"Patric A","family":"Winzap","sequence":"first","affiliation":[{"name":"Center for Molecular Cardiology, University of Zurich , Wagistrasse, Schlieren 8952 , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8245-7287","authenticated-orcid":false,"given":"Simon","family":"Kraler","sequence":"additional","affiliation":[{"name":"Center for Molecular Cardiology, University of Zurich , Wagistrasse, Schlieren 8952 , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slayman","family":"Obeid","sequence":"additional","affiliation":[{"name":"Cardiology, Cantonal Hospital Aarau , Aarau , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6654-9918","authenticated-orcid":false,"given":"Florian A","family":"Wenzl","sequence":"additional","affiliation":[{"name":"Center for Molecular Cardiology, University of Zurich , Wagistrasse, Schlieren 8952 , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Templin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospital Zurich , Zurich , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Klingenberg","sequence":"additional","affiliation":[{"name":"Kerckhoff Heart and Thorax Centre, Department of Cardiology , Kerckhoff-Klinik, Bad Nauheim , Germany"},{"name":"Campus of the Justus Liebig University of Giessen , Giessen , Germany"},{"name":"German Center for Cardiovascular Research (DZHK) , Partner site Rhein-Main, Bad Naunheim , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1666-2266","authenticated-orcid":false,"given":"Arnold","family":"von Eckardstein","sequence":"additional","affiliation":[{"name":"Institute for Clinical Chemistry, University Hospital Zurich , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3051-0170","authenticated-orcid":false,"given":"Marco","family":"Roffi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, H\u00f4pitaux Universitaires de Gen\u00e8ve , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2441-5799","authenticated-orcid":false,"given":"Olivier","family":"Muller","sequence":"additional","affiliation":[{"name":"Cardiology, Centre Hospitalier Universitaire Vaudois , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz","family":"R\u00e4ber","sequence":"additional","affiliation":[{"name":"Cardiology, Swiss Heart Centre , Inselspital, Bern , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5259-538X","authenticated-orcid":false,"given":"Thomas F","family":"L\u00fcscher","sequence":"additional","affiliation":[{"name":"Center for Molecular Cardiology, University of Zurich , Wagistrasse, Schlieren 8952 , Switzerland"},{"name":"Royal Brompton and Harefield Hospitals and Imperial College and Kings College , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"SPUM-ACS investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Mach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Matter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Rodondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Nanchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Carballo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Gencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Pfisterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Kappenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziano","family":"Moccetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Rigamonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"K\u00e4lin-Weeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Peereboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Seiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,5,8]]},"reference":[{"key":"2023070718443581900_zuad047-B1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/eurheartj\/ehz859","article-title":"Cardiovascular disease statistics 2019 (executive summary)","volume":"41","author":"European Society of Cardiology","year":"2020","journal-title":"Eur Heart J"},{"key":"2023070718443581900_zuad047-B2","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1161\/01.CIR.102.17.2031","article-title":"TIMI Risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation","volume":"102","author":"Morrow","year":"2000","journal-title":"Circulation"},{"key":"2023070718443581900_zuad047-B3","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/bmj.38985.646481.55","article-title":"Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)","volume":"333","author":"Fox","year":"2006","journal-title":"BMJ"},{"key":"2023070718443581900_zuad047-B4","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1093\/eurheartj\/ehab285","article-title":"2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European society of cardiology (ESC)","volume":"42","author":"European Society of Cardiology","year":"2021","journal-title":"Eur Heart J"},{"key":"2023070718443581900_zuad047-B5","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1177\/2048872617690888","article-title":"Impact of acute infarct-related artery patency before percutaneous coronary intervention on 30-day outcomes in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention in the EUROMAX trial","volume":"7","author":"Rakowski","year":"2018","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2023070718443581900_zuad047-B6","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/ehjacc\/zuac020","article-title":"Effects of early myocardial reperfusion and perfusion on myocardial necrosis\/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial","volume":"11","author":"Batra","year":"2022","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2023070718443581900_zuad047-B7","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1093\/eurheartj\/ehx569","article-title":"From Eisenhower\u2019s heart attack to modern management: a true success story!","volume":"38","author":"L\u00fcscher","year":"2017","journal-title":"Eur Heart J"},{"key":"2023070718443581900_zuad047-B8","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1093\/eurheartj\/ehz363","article-title":"Management of cardiogenic shock complicating myocardial infarction: an update 2019","volume":"40","author":"Thiele","year":"2019","journal-title":"Eur Heart J"},{"key":"2023070718443581900_zuad047-B9","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1056\/NEJMc1902949","article-title":"One-year outcomes after PCI strategies in cardiogenic shock","volume":"380","author":"Thiele","year":"2019","journal-title":"N Engl J Med"},{"key":"2023070718443581900_zuad047-B10","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1056\/NEJMc1802622","article-title":"PCI Strategies in acute myocardial infarction with cardiogenic shock","volume":"378","author":"Thiele","year":"2018","journal-title":"N Engl J Med"},{"key":"2023070718443581900_zuad047-B11","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"Intraaortic balloon support for myocardial infarction with cardiogenic shock","volume":"367","author":"Thiele","year":"2012","journal-title":"N Engl J Med"},{"key":"2023070718443581900_zuad047-B12","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.CIR.0000158479.58589.0A","article-title":"Inflammatory markers at the site of ruptured plaque in acute myocardial infarction","volume":"111","author":"Maier","year":"2005","journal-title":"Circulation"},{"key":"2023070718443581900_zuad047-B13","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/eurheartj\/ehu203","article-title":"Anti-inflammatory therapies for cardiovascular disease","volume":"35","author":"Ridker","year":"2014","journal-title":"Eur Heart J"},{"key":"2023070718443581900_zuad047-B14","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"2023070718443581900_zuad047-B15","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"key":"2023070718443581900_zuad047-B16","doi-asserted-by":"crossref","first-page":"e13424","DOI":"10.1111\/eci.13424","article-title":"Repurposing colchicine to combat residual cardiovascular risk: the LoDoCo2 trial","volume":"50","author":"Kraler","year":"2020","journal-title":"Eur J Clin Invest"},{"key":"2023070718443581900_zuad047-B17","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0140-6736(22)01483-0","article-title":"Sex-specific evaluation and redevelopment of the GRACE score in non-ST-segment elevation acute coronary syndromes in populations from the UK and Switzerland: a multinational analysis with external cohort validation","volume":"400","author":"Wenzl","year":"2022","journal-title":"Lancet"},{"key":"2023070718443581900_zuad047-B18","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1093\/eurheartj\/ehac143","article-title":"Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts premature death in acute coronary syndromes","volume":"43","author":"Kraler","year":"2022","journal-title":"Eur Heart J"},{"key":"2023070718443581900_zuad047-B19","first-page":"3021","article-title":"The task force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). 2018 ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","year":"2019","journal-title":"Eur Heart J"},{"key":"2023070718443581900_zuad047-B20","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12933-019-0946-6","article-title":"Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61","volume":"18","author":"Winzap","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"2023070718443581900_zuad047-B21","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-060953","article-title":"Management and outcomes over time of acute coronary syndrome patients at particularly high cardiovascular risk: the ACSIS registry-based retrospective study","volume":"12","author":"Grinberg","year":"2022","journal-title":"BMJ Open"},{"key":"2023070718443581900_zuad047-B22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199408183310701","article-title":"The prognostic value of C-reactive protein and Serum amyloid A protein in severe unstable angina","volume":"331","author":"Liuzzo","year":"1994","journal-title":"N Engl J Med"},{"key":"2023070718443581900_zuad047-B23","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ijcard.2005.06.021","article-title":"C-reactive protein in patients with acute coronary syndrome: correlation with diagnosis, myocardial damage, ejection fraction and angiographic findings","volume":"109","author":"Brunetti","year":"2006","journal-title":"Int J Cardiol"},{"key":"2023070718443581900_zuad047-B24","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1161\/CIRCULATIONAHA.117.029870","article-title":"Acute coronary syndromes: the way forward from mechanisms to precision treatment","volume":"136","author":"Crea","year":"2017","journal-title":"Circulation"},{"key":"2023070718443581900_zuad047-B25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-020-0352-5","article-title":"T cell subsets and functions in atherosclerosis","volume":"17","author":"Saigusa","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"2023070718443581900_zuad047-B26","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1172\/JCI117619","article-title":"Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques","volume":"94","author":"Galis","year":"1994","journal-title":"J Clin Invest"},{"key":"2023070718443581900_zuad047-B27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/eurheartj\/ehaa099","article-title":"Targeting cardiovascular inflammation: next steps in clinical translation","volume":"42","author":"Lawler","year":"2021","journal-title":"Eur Heart J"},{"key":"2023070718443581900_zuad047-B28","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1016\/j.jacc.2011.08.055","article-title":"High-Sensitivity C-reactive protein is within normal levels at the very onset of first ST-segment elevation acute myocardial infarction in 41% of cases: a multiethnic case-control study","volume":"58","author":"Cristell","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2023070718443581900_zuad047-B29","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/ehjacc\/zuab003","article-title":"Prognostic value of inflammatory biomarkers and GRACE score for cardiac death and acute kidney injury after acute coronary syndromes","volume":"10","author":"Rossi","year":"2021","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2023070718443581900_zuad047-B30","doi-asserted-by":"crossref","DOI":"10.1093\/ehjacc\/zuad018","article-title":"Inflammatory response by 48 h after admission and mortality in patients with acute myocardial infarction complicated by cardiogenic shock","author":"Kunkel","year":"2023","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2023070718443581900_zuad047-B31","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1177\/2048872616661691","article-title":"Relation of inflammatory markers with myocardial and microvascular injury in patients with reperfused ST-elevation myocardial infarction","volume":"6","author":"Reindl","year":"2017","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2023070718443581900_zuad047-B32","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/2048872615568965","article-title":"Inflammatory markers in ST-elevation acute myocardial infarction","volume":"5","author":"Seropian","year":"2016","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2023070718443581900_zuad047-B33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jash.2014.11.005","article-title":"The association between elevated admission systolic blood pressure in patients with acute coronary syndrome and favorable early and late outcomes","volume":"9","author":"Shlomai","year":"2015","journal-title":"J Am Soc Hypertens"},{"key":"2023070718443581900_zuad047-B34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/brbi.2000.0597","article-title":"The relationship of depression and stressors to immunological assays: A meta-analytic review","volume":"15","author":"Zorrilla","year":"2001","journal-title":"Brain Behav Immun"},{"key":"2023070718443581900_zuad047-B35","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/CIRCRESAHA.116.304653","article-title":"Release kinetics of inflammatory biomarkers in a clinical model of acute myocardial infarction","volume":"116","author":"Liebetrau","year":"2015","journal-title":"Circ Res"},{"key":"2023070718443581900_zuad047-B36","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1001\/jama.2021.18323","article-title":"Cardiogenic shock after acute myocardial infarction","volume":"326","author":"Samsky","year":"2021","journal-title":"JAMA"},{"key":"2023070718443581900_zuad047-B37","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1001\/archinte.165.14.1643","article-title":"Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock","volume":"165","author":"Kohsaka","year":"2005","journal-title":"Arch Intern Med"},{"key":"2023070718443581900_zuad047-B38","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1126\/science.1230719","article-title":"Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure","volume":"339","author":"Swirski","year":"2013","journal-title":"Science"},{"key":"2023070718443581900_zuad047-B39","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1177\/2048872619896063","article-title":"Biomarkers predictive of late cardiogenic shock development in patients with suspected ST-elevation myocardial infarction","volume":"9","author":"Frydland","year":"2020","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2023070718443581900_zuad047-B40","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004425","article-title":"Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score","volume":"4","author":"Fox","year":"2014","journal-title":"BMJ Open"},{"key":"2023070718443581900_zuad047-B41","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/ehjacc\/zuab030","article-title":"Improving 1-year mortality prediction in ACS patients using machine learning","volume":"10","author":"Weichwald","year":"2021","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2023070718443581900_zuad047-B42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/2450569","article-title":"Immune and inflammation in acute coronary syndrome: molecular mechanisms and therapeutic implications","volume":"2020","author":"Wang","year":"2020","journal-title":"J Immunol Res"},{"key":"2023070718443581900_zuad047-B43","article-title":"SGLT-2 inhibition by empagliflozin has no effect on experimental arterial thrombosis in a murine model of low-grade inflammation","author":"Liberale","year":"2022","journal-title":"Cardiovasc Res Preprint"},{"key":"2023070718443581900_zuad047-B44","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fcvm.2018.00062","article-title":"Antiinflammatory therapy in clinical care: the CANTOS trial and beyond","volume":"5","author":"Aday","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"2023070718443581900_zuad047-B45","doi-asserted-by":"crossref","first-page":"e2690","DOI":"10.6061\/clinics\/2021\/e2690","article-title":"Meta-analysis of the relationship between interleukin-6 levels and the prognosis and severity of acute coronary syndrome","volume":"76","author":"Yang","year":"2021","journal-title":"Clinics (Sao Paulo)"}],"container-title":["European Heart Journal: Acute Cardiovascular Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjacc\/advance-article-pdf\/doi\/10.1093\/ehjacc\/zuad047\/50339656\/zuad047.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjacc\/article-pdf\/12\/7\/437\/50839917\/zuad047.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjacc\/article-pdf\/12\/7\/437\/50839917\/zuad047.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T18:46:17Z","timestamp":1688755577000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjacc\/article\/12\/7\/437\/7157005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,8]]},"references-count":45,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,5,8]]},"published-print":{"date-parts":[[2023,7,7]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjacc\/zuad047","relation":{},"ISSN":["2048-8726","2048-8734"],"issn-type":[{"value":"2048-8726","type":"print"},{"value":"2048-8734","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,7]]},"published":{"date-parts":[[2023,5,8]]}}}